Research Grants

For research that focuses on leukaemia, lymphoma or blood related diseases

Eligibility

• The scheme is open to researchers in all faculties and institutes of the University of Tasmania; departments within Tasmanian hospitals; and the Department of Health and Human Services.
• The research must focus on leukaemia, lymphoma or blood related diseases. It includes population health strategies, medical research, clinical and psychosocial care.
• An individual can only be listed on one grant as a lead chief investigator (CI) at any one time. Achievement of deliverables on previous DCLFofT grants will be considered when assessing requests.
• Closing date and time of the scheme, formatting length and supporting documentation requirements must be strictly adhered to. Applicants not meeting these requirements will not be eligible for funding.

Assessment Criteria

• Quality of the research proposal, including feasibility and budget (50%)
• Research capacity, including track record and research team (25%)
• Applications with an early career researcher as the lead investigator will receive additional 20%  weighting in this category. Please indicate on the form if you are an early career researcher. This includes those who obtained their PhD or highest degree ≤ 5 FTE years ago or who have had no grants as a lead investigator (>$10,000). If you are unsure whether you meet this criterion, please contact DCLFofT.
• Research significance and innovation, including alignment with the strategic direction of DCLFofT and broader contribution to the field of research (25%).

Assessment Process

• Full electronic applications must be submitted to enquiries@leukaemia-tasmania.com.au.
• Applications will be distributed to the relevant review panel.
• Members of the panel will individually assess, score and rank applications.
• Ranked applications will then be discussed at a DCLFofT meeting to consolidate a score and ranking.
• The committee of DCLFofT will then make a funding recommendation.
• Applicants will be informed of their outcome in early 2020.

Conditions of Grant

• The term of each funding round will be 12 months.
• Research funding must be spent, as outlined in the application, by the project close date. Unspent funds will be reclaimed.
• A Final Report must be submitted.
• No part of the funding is to be used for external conference attendance.
• If a sole CI leaves their current employment, then the grant must be relinquished.
• Funding cannot be used for salaries, or to fund a Research Higher Degree candidate’s stipend or fees.

Funding is subject to investigators obtaining relevant ethics committee approvals.

Applications close 1st March 2020